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Abstract
Towards the goal of development of a generic nanomaterial delivery system and delivery of the ‘as prepared’ nanoparticles
without ‘further surface modification’ in a generic way, we have fabricated a hybrid polymer capsule as a delivery vehicle in
which nanoparticles are loaded within their cavity. To this end, a generic approach to prepare nanomaterials-loaded
polyelectrolyte multilayered (PEM) capsules has been reported, where polystyrene sulfonate (PSS)/polyallylamine
hydrochloride (PAH) polymer capsules were employed as nano/microreactors to synthesize variety of nanomaterials (metal
nanoparticles; lanthanide doped inorganic nanoparticles; gadolinium based nanoparticles, cadmium based nanoparticles;
different shapes of nanoparticles; co-loading of two types of nanoparticles) in their hollow cavity. These nanoparticles-
loaded capsules were employed to demonstrate generic delivery of payload of nanoparticles intracellularly (HeLa cells),
without the need of individual nanoparticle surface modification. Validation of intracellular internalization of nanoparticles-
loaded capsules by HeLa cells was ascertained by confocal laser scanning microscopy. The green emission from Tb
3+ was
observed after internalization of LaF3:Tb
3+(5%) nanoparticles-loaded capsules by HeLa cells, which suggests that
nanoparticles in hybrid capsules retain their functionality within the cells. In vitro cytotoxicity studies of these nanoparticles-
loaded capsules showed less/no cytotoxicity in comparison to blank capsules or untreated cells, thus offering a way of
evading direct contact of nanoparticles with cells because of the presence of biocompatible polymeric shell of capsules. The
proposed hybrid delivery system can be potentially developed to avoid a series of biological barriers and deliver multiple
cargoes (both simultaneous and individual delivery) without the need of individual cargo design/modification.
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Introduction
Nanomaterials have attracted a great deal of interest in diverse
fields, in particular bioimaging, drug delivery, and biosensing [1].
Different kinds of nanomaterials have been used in a variety of
imaging applications such as X-ray computed tomography (noble
metal nanoparticles-Au, Ag), near-IR optical imaging (noble metal
nanoparticles-Au, Ag), fluorescence based imaging (semiconductor
quantum dots, lanthanide-doped nanoparticles), magnetic reso-
nance imaging (Iron and gadolinium based materials) etc [2]. For
diagnostic and therapeutic applications in biomedicine, nanopar-
ticles must overcome a series of biological barriers (degradation/
aggregation in body fluids, phagocytic clearance by reticulo-
endothelial system, crossing of the plasma membrane etc) so as to
ultimately perform their desired function [2]. Designing of
nanomaterials to provide them with the ability of evading these
hurdles and achieving desired localization, is key for exploiting
their true potential for biomedical applications. For instance,
intracellular delivery of nanoparticles can be achieved by
engineering the physical (e.g. size and shape) and surface
properties (charge, chemical and biomoities) of the nanoparticles
[3–5]. However, this may require multiple step processes to
achieve the required physical/surface properties of nanoparticles
which can lead to aggregation and reduction in the desired
properties (e.g. optical, magnetic, electrical, etc) of nanoparticles.
Additionally, these multiple step processes can be different for
different types of nanoparticles. To circumvent these issues, it is
desired to have a generic delivery system to deliver the
nanoparticle intracellularly without any individual nanoparticle
surface modification. Moreover, the delivery system can serve the
purpose of avoiding direct contact of the nanoparticles with the
body fluids, and thus avoid degradation/aggregation of nanopar-
ticles and their clearance by phagocytic cells. Fabrication of
a generic nanomaterial delivery system encompasses different tasks
namely, employment of a generic method to load different kinds of
nanomaterials in a delivery vehicle, which in itself is capable/
designed of avoiding physiological barriers and using this
nanomaterial-loaded vehicle to finally deliver the cargo intracel-
lularly. To this end, we have explored the prospect of loading
variety of nanomaterials inside the cavity of polymer capsules and
use them as generic nanomaterial delivery systems without
individual nanoparticle design/surface modification.
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vehicles is based on their increasingly potential applications such
as drug delivery, biosensing, bioimaging, catalysis and biomedicine
[6–12]. Additionally, these PEM capsules can be used as
multifunctional biovehicle because, their physico-chemical prop-
erties (e.g. size, composition, porosity and surface functionality)
can be easily tailored and controlled [13]. Integration of
nanoparticles with polymer capsules is desirable for multifunc-
tional applications (release of cargo, enhance mechanical proper-
ties, etc) [14,15], and can be achieved by incorporating
nanoparticles within the two available compartments in PEM
capsules, namely- shell and the cavity. To this end of loading
nanoparticles in the shell of polymer capsules, few reports are
available on the development of multifunctional PEM capsules
which possess optical/magnetic nanoparticles sandwiched between
the PEM layers along with the prospect of filling the cavity with
desirable cargo [16–19]. Koo et al. have reported loading of gold
nanorods on the surface of polymer capsules [20]. However, this
approach of loading of ‘pre-synthesized nanoparticles’ within the
shell has limitations such as lesser loading of nanoparticles [21],
possible release of nanoparticles before reaching the targeted site
due to disruption of few layers of polymers, and change in the
property of nanoparticles [22]. Recently, Caruso and his co-
workers have shown the synthesis of magnetic nanoparticles/QDs-
loaded PEM capsules by using preformed nanoparticles in the
emulsion template [23]. Even loading of pre-synthesized nano-
particles in template may also lead to change in property of
nanoparticles as the nanoparticles will be exposed to the process of
capsule synthesis (e.g. emulsification etc) and template removal. To
circumvent these issues of using ‘pre-synthesized nanoparticles’
either in the shell or cavity, the nanoparticles can be loaded inside
the cavity of polymer capsules, by synthesizing them within the
capsule interior. Shchukin et al. have reported synthesis of YF3 (for
yttrium recovery from aqueous solutions) and rare earth
phosphates nanoparticles in polyelectrolyte capsules [24,25].
However, to our knowledge, there is no report available on
a general approach to ‘synthesize’ variety of nanomaterials inside
the ‘cavity’ of polymer capsules and generic delivery of
nanoparticles via polymer capsules.
The proposed work attempts to address the challenge of
fabrication of generic nanomaterial delivery system by dealing
with it at two different steps. Firstly, we have employed a general
and versatile method to synthesize variety of nanomaterials inside
the cavity of polymer capsules by templating polystyrene sulfonate
(PSS)/polyallylamine hydrochloride (PAH) and cross-linked PAH
polymer capsules as micro/nanoreactors. Secondly, nanoparticles-
loaded capsules were interacted with human cervical cancer cells
(HeLa) to deliver the ‘as prepared’ nanoparticles in a functional
state intracellularly, without needing individual nanoparticle
design/surface modification. In this report, the microvolume of
polymer capsules was exploited to synthesize gold, silver, cadmium
sulfide and lanthanide ion-doped nanoparticles (LaF3:Tb
3+(5%),
LaVO4:Eu
3+(5%), GdF3:Tb
3+(5%)), stabilized with citrate ligand
inside the PSS/PAH capsule. In addition, different shapes of gold
nanostructures (nanorods, nanoprisms, and multifaceted nanos-
tructures) and co-loading of two types of nanoparticles within the
same polymer capsule have been demonstrated. We have also
demonstrated the co-loading of protein (RITC-BSA; Rhodamine
B isothiocyanate-bovine serum albumin) along with gold nano-
particles for potential stimuli-responsive (e.g. laser) drug delivery
applications. Furthermore, different sizes of polymer capsules
(400 nm, 1 mm, and 5 mm) have been used as nano/microreactors
to synthesize gold nanoparticles and to prove the generality and
versatility of our method. Interaction of these nanoparticles-loaded
PSS/PAH capsules with HeLa cells was examined for uptake
kinetics and in vitro cytotoxicity studies, thereby demonstrating
a generic platform for delivery of a variety of nanoparticles to cells.
We have demonstrated synthesis of a) metal nanoparticles (Au and
Ag) in capsules as candidates for potential micro-CT imaging
applications and laser induced release of cargo, b) lanthanide ion
doped inorganic nanoparticles (LaF3:Tb
3+, LaVO4:Eu
3+ and
GdF3:Tb
3+) and CdS nanoparticles as candidates for fluorescence
based imaging applications and c) GdF3 nanoparticles as MRI
contrast agents. One of the nanoparticles-loaded capsules was used
to demonstrate fluorescence based imaging in HeLa cells in vitro.
This approach has several advantages from the standpoint of
both generic synthesis and generic delivery of nanomaterials: (i)
this method can be applied to load variety of nanoparticles (e.g.
Au, Ag, CdS, LaF3, GdF3, LaVO4, etc.) inside the polymer
capsule along with loading of therapeutic molecules (e.g. RITC-
BSA); (ii) different kinds of nanoparticles can be simultaneously
loaded inside the capsule (e.g. Au and LaVO4); (iii) different shapes
of nanomaterials can be loaded (e.g. gold nanorods, nanoprisms,
multifaceted nanostructures) (iv) size, composition, and morphol-
ogy of capsules/nanoparticles can be easily tailored and
controlled; (v) the number of nanoparticles inside the polymer
capsules can be easily controlled by varying the concentration of
nanoparticle precursors; (vi) variety of nanoparticles can be
delivered intracellularly without individual nanoparticle surface
modification (e.g. ‘as prepared’ Au and LaF3:Tb
3+ nanoparticles
were delivered intracellularly to HeLa cells via polymer capsules);
(viii) prevention of nanoparticle exposure to body fluids, avoidance
of any nanoparticle release/degradation/change in property
before reaching the target, evading direct contact of nanoparticles
with cells and generic delivery of a payload of nanoparticles
without the step of nanomaterial surface functionalization/design
(of every single nanoparticle; required for all types of nanoparticles
and is different for different types of nanoparticles) needed for
delivery and avoidance of biological barriers.
These hybrid polymer capsules can be potentially used as active
targeting (surface modification with ligands/antibodies) as well as
passive targeting (based on their size, ,300–700 nm) [26,27].
Moreover, these nanomaterials-loaded PEM capsules can be
potentially used as multimodal bioimaging agents [28,29] (mag-
netic resonance imaging (MRI), X-ray computed tomography
(CT), fluorescence imaging, and nuclear imaging), drug delivery
vehicles and biosensors. Loading of multiple cargoes (simultaneous
loading of two types of nanoparticles/simultaneous loading of
nanoparticles and therapeutics) within the capsule can be explored
to design multifunctional vehicles for biomedical applications [30].
In addition, the residence time of these nanoparticles-loaded
polymer capsules can potentially be longer in the affected tissues
compared to bare nanoparticles (size ,20 nm) which can facilitate
better imaging of affected tissues. One has to bear in mind that the
residence time of nanoparticles in the affected tissues depends on
their size, shape, and surface [27].
Results and Discussion
Generic Method to Prepare Nanoparticles-Loaded
Capsules
Scheme S1 shows the schematic representation of synthesis of
nanomaterials-loaded polymer capsules. The PSS/PAH capsules
were formed via layer-by-layer (LbL) assembly of polymers on
monodisperse silica particles (size ,5 mm) followed by removal of
the core by etching with HF. Further, these capsules were
incubated in nanoparticle precursor salts solution along with
citrate ions as ligand. The excess nanoparticles formed outside the
Generic Delivery of Nanoparticles to Cells
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36195polymer capsules were removed by washing thrice with water. All
the nanoparticles-loaded polymer capsules were easily dispersible
in PBS buffer (pH,7.2) as can be observed from the digital image
(Scheme S1 inset). Figure 1a demonstrates the UV-Vis absorption
spectra of Au and Ag nanoparticles-loaded PSS/PAH capsules.
The appearance of absorbance peaks due to surface plasmon
resonance at ,524 nm (green curve) and ,400 nm (red curve)
suggest the formation of gold and silver nanoparticles, respectively.
Furthermore, the absorbance of nanoparicles-loaded capsules
matches with the absorbance of blank nanoparticles (Figure S1).
Figure 1b shows the photoluminescence (PL) emission spectra of
LaF3:Tb
3+(5%), LaVO4:Eu
3+(5%), and GdF3:Tb
3+(5%) nanopar-
ticles-loaded PSS/PAH capsules by excitation with laser. The
emission bands (black and red curve, Figure 1b) around 544, 584
and 619 nm are assigned to
5D4 to
7F5,
7F4, and
7F3 transitions,
respectively of Tb
3+ ions. In addition, the average life time of Tb
3+
ions in LaF3 and GdF3 are 1.7 ms and 2.8 ms, respectively, which
clearly suggests that the Tb
3+ ions are doped in an inorganic
matrix.[31] The emission bands around 591 nm (
5D0 to
7F1),
615 nm (
5D0 to
7F2), and 696 nm (
5D0 to
7F4) are assigned to Eu
3+
ions. Additionally, the average lifetime of Eu
3+ is reported to be
5.3 ms. (Table S2 and Figure S2) [31]. We note that, the
background emission in PL emission spectra arises from blank
PSS/PAH capsules (Figure S3). Furthermore, the optical proper-
ties of the nanoparticles-loaded capsules match with the blank
nanoparticles (Figure S4), which clearly suggested that properties
of nanoparticles do not change when trapped inside the polymer
capsule. Over all, the nanoparticles-loaded PSS/PAH capsules
show excellent optical properties warranting their potential for
various bioimaging applications.
The size and surface morphology of nanoparticles-loaded PSS/
PAH capsules have been characterized by transmission electron
microscopy (TEM) and scanning electron microscopy (SEM).
Figure 2 demonstrates the TEM image of Au, Ag, La-
VO4:Eu
3+(5%), LaF3:Tb
3+(5%), CdS, and GdF3:Tb
3+(5%) nano-
particles-loaded PSS/PAH capsules. The contrast in the TEM
image clearly shows that the interior of the polymer capsules are
loaded with nanoparticles and the size/shape of the nanoparticles
are uniform. As can be observed in the TEM images, the cavity
has more contrast when compared to the walls of the capsule,
which clearly suggests that the nanoparticles are inside the
polymer capsules (if the particles were in the wall, the contrast
of the wall of the polymer capsules would have been more as
compared to cavity). High loading of nanoparticles can be
observed in figure 2a and 2b, showing gold and silver
nanoparticles in the size range of 5–10 nm and 5–15 nm
respectively. We note that the aggregation observed in the TEM
images is due to the drying effect during the sample preparation.
To validate the formation of nanoparticles inside polymer
capsules, the nanoparticles-loaded polymer capsules were sub-
jected to SEM analysis. The surface morphology of blank capsules
and gold nanoparticles-loaded polymer capsules are similar, which
clearly suggests that nanoparticles are not on the surface of the
PEM capsules (Figure 3). The synthesis of different kinds of
nanoparticles inside the polymer capsule clearly proves the
generality and versatility of our approach.
Figure 4a, 4b and 4c shows TEM images of PSS/PAH capsules
loaded with different shapes of gold nanostructures, namely gold
nanoprisms, gold nanorods and multifaceted gold nanostructures
respectively. Figure 4b and 4c suggests that the formation of gold
nanorods and multifaceted nanostructures inside the polymer
capsule. It was also observed that the capsules possess seed gold
particles along with gold nanoprisms. We note that Murphy et al.
have reported that the synthesis of uniform size and shape of gold
nanorods is a challenging process; however, they have improved
the yield of nanorods by centrifugation processes [32]. Selective
synthesis of different shapes of nanostructures by templating
polymer capsules will be further investigated to evade the
separation steps. This shows the versatility of the approach in
terms of control on shape and adaptability of seed mediated
growth of nanoparticles within the capsule. Figure S5a and S5b
shows the UV-Vis absorption spectra of PSS/PAH capsules
loaded with gold nanorods and multifaceted gold nanostructures
respectively. The absorbance in the NIR region further suggests
the formation of nanorods and multifaceted nanostructures. This
clearly suggests that these capsules loaded with different shapes of
nanomaterials can further widen their applications such as stimuli
(near infra red (NIR)) responsive drug delivery, photothermal
ablation therapy, etc [16,33].
Co-loading of two types of nanoparticles inside PSS/PAH
capsules was done by loading the capsules with LaVO4:Eu
3+(5%)
nanoparticles first and then using these LaVO4:Eu
3+(5%)
nanoparticles-loaded capsules for synthesis of gold nanoparticles.
As can be observed from TEM image (Figure 4d), the polymer
capsules were successfully loaded with two types of particles having
different electron densities. The lighter particles (marked with
black arrow) are LaVO4:Eu
3+(5%) nanoparticles and gold
nanoparticles are the darker particles (marked with white colored
Figure 1. Optical properties of nanoparticles-loaded PSS/PAH capsules. (a) UV-Vis absorbance spectra of (1) Ag and (2) Au nanoparticles-
loaded PSS/PAH capsules and (3) blank PSS/PAH capsules; (b) photoluminescence emission spectra of (1) GdF3:Tb
3+(5%), (2) LaF3:Tb
3+(5%) and (3)
LaVO4:Eu
3+(5%) nanoparticles-loaded PSS/PAH capsules [Excitation wavelength used was 488 nm for GdF3:Tb
3+(5%) and LaF3:Tb
3+(5%) and 465 nm
for LaVO4:Eu
3+(5%)].
doi:10.1371/journal.pone.0036195.g001
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spectroscopy of Au and LaVO4:Eu
3+-loaded polymer capsules
which indicates the presence of La and Au. This further confirms
the co-loading of LaVO4:Eu
3+(5%) and gold nanoparticles inside
the PSS/PAH capsules. The PSS/PAH capsules co-loaded with
LaVO4:Eu
3+(5%) and gold nanoparticles were further investigated
for their optical properties to ensure the functionality of the two
types of nanoparticles within the capsule interior. Figure 5a shows
Figure 2. Validation of nanoparticle presence inside the PSS/PAH capsules. Representative TEM image of (a) Au, (b) Ag, (c) LaVO4:Eu
3+(5%),
(d) LaF3:Tb
3+(5%), (e) CdS, and (f) GdF3:Tb
3+(5%) nanoparticles-loaded PSS/PAH capsules. (Inset in each figure shows the respective nanoparticles-
loaded PSS/PAH capsule at lower magnification.).
doi:10.1371/journal.pone.0036195.g002
Figure 3. Surface characterization of nanoparticles-loaded PSS/PAH capsules. Scanning electron micrograph of (a) Au nanoparticles-
loaded PSS/PAH capsules and (b) blank PSS/PAH capsules.
doi:10.1371/journal.pone.0036195.g003
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co-loaded with LaVO4:Eu
3+(5%) and gold nanoparticles, depict-
ing the presence of emission bands around 591 nm (
5D0 to
7F1),
615 nm (
5D0 to
7F2), and 696 nm (
5D0 to
7F4), which are assigned
to Eu
3+ ions. The absorbance peak at 529 nm in Figure 5b
indicates the formation of gold nanoparticles in the co-loaded
capsules. We note that the life time of Eu
3+ ions (Table S2) is less
in co-loaded sample (LaVO4:Eu
3+(5%) and Au; 1.6 ms) when
compared to LaVO4:Eu
3+(5%)(5.3 ms)-loaded polymer capsule.
We depict that the reduction in life time may be due to reduction
in sizes of LaVO4 nanoparticles.
To demonstrate further the generality of our method three
different sized polymer capsules were employed for synthesis of
gold nanoparticles, namely 5 mm PSS/PAH capsules, 1 mm PSS/
PAH capsules and cross-linked PAH nanocapsules (, 400 nm).
Gold nanoparticles were successfully synthesized inside all the
three types of capsules as can be observed in Figure 2a, 6a and 6b.
The PSS/PAH capsules were co-loaded with RITC-BSA (model
drug) and Au nanoparticles to exhibit the multifunctionality of the
proposed hybrid materials. To confirm the loading of RITC-BSA,
the loaded capsules were subjected to fluorescence microscopy
(Figure S6), where the red emission corresponds to the presence of
RITC-BSA in the interior of the polymer capsule. These RITC-
BSA loaded capsules were then used as templates to synthesize Au
nanoparticles by the same method as described above.
Versatility and generality of the approach was emphasized by
synthesizing different shaped nanoparticles (nanorods, nanopr-
isms, and multifaceted nanostructures), co-loading of two types of
nanoparticles and co-loading of protein along with Au nanopar-
ticles inside PSS/PAH capsules. Nanoparticle loading inside these
Figure 4. PSS/PAH capsules loaded with different shapes of nanoparticles and co-loaded with two types of nanoparticles. TEM image
of PSS/PAH capsules loaded with (a) gold nanoprism, (b) gold nanorods, (c) multifaceted gold nanostructures and (d) Au and LaVO4:Eu
3+(5%)
nanoparticles (co-loaded, black and white arrow show LaVO4:Eu
3+(5%) and Au nanoparticles respectively.).
doi:10.1371/journal.pone.0036195.g004
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citrate as ligand for all the nanoparticles loaded (Au, Ag, CdS,
LaF3, GdF3, LaVO4). Loading of gold nanoparticles inside
different sized capsules (PSS/PAH capsules [5 mm, 1 mm] and
cross-linked PAH nanocapsules [,400 nm]) further highlights the
generality of our approach.
Delivery of Nanoparticles Payload to Cancer Cells
In order to investigate the delivery capabilities of these
nanoparticles-loaded capsules, they were subjected to interaction
with HeLa cells. Figure 7 shows the uptake kinetics of
LaF3:Tb
3+(5%) nanoparticles-loaded PSS/PAH capsules as
a function of incubation time with HeLa cells, where the uptake
was followed by fluorescence microscopy and scanning electron
microscopy. To visualize the uptake by fluorescence microscopy,
LaF3:Tb
3+(5%) nanoparticles were loaded in RITC-labeled
capsules (red emission) so as to locate the nanoparticles-loaded
capsules during the internalization process. The uptake of
nanoparticles-loaded capsules by HeLa cells has started around
2–5 hours as binding events [binding of nanoparticles-loaded
RITC-labeled capsules (red) to cells (green)] can be observed
(Figure 7a, 7b, 7d and 7e) during that durations. Moreover,
internalization events can be observed around 8 hours (Figure 7c
and 7f) suggesting that the internalization process has initiated
around 2–5 hours and is probably near completion around
8 hours of treatment. Further, uptake of LaF3:Tb
3+(5%) and Au
nanoparticles-loaded capsules by HeLa cells was visualized by
confocal laser scanning microscopy (CLSM) after 16 hours of
incubation, where it can be observed that most of the cells (green
emission) have internalized the nanoparticles-loaded capsules (red
emission from RITC of capsule) (Figure 8a). Moreover, it can
also be seen that the internalized capsules are collapsed (Figure 8a
inset) suggesting their uptake (also observed in other reports)
[34]. CLSM imaging of various Z stacks of cells (Figure S7) after
the incubation with nanoparticles-loaded capsules clearly suggests
that the nanoparticles-loaded polymer capsules were efficiently
internalized by the cells, thus delivering the payload of
nanoparticles to the cells. Efficiency of uptake of Au nanopar-
ticles-loaded capsules and blank PSS/PAH capsules by HeLa
cells was investigated by flow cytometry to inspect differences in
uptake. There was no significant difference in efficiency of uptake
of nanoparticles-loaded capsules and blank capsules by HeLa
Figure 5. Optical properties of PSS/PAH capsules co-loaded with two types of nanoparticles. (a) Photoluminescence emission spectrum,
(b) UV-Vis absorption spectrum and (c) EDX analysis of PSS/PAH capsules co-loaded with Au and LaVO4:Eu
3+(5%) nanoparticles.
doi:10.1371/journal.pone.0036195.g005
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average percentage positive cells was 72.85% and 79.25% for
nanoparticles-loaded capsules and blank capsules respectively.
This suggests that the process of loading of nanoparticles inside
these PSS/PAH capsules does not affect the properties of the
capsules required for uptake by the cells. The percentage positive
cells were estimated from the 2D dot plots of the events
corresponding to association/uptake of the nanoparticles-loaded
polymer capsules by the HeLa cells (Figure S8). Events with high
forward scattering and high fluorescence intensity were assigned
to capsules/nanoparticles-loaded capsules bound/internalized
with the cells. Events with low forward scattering and high
fluorescence intensity correspond to free capsules/nanoparticles-
loaded capsules. Only cells show high forward scattering with low
fluorescence intensity.
Post uptake, examination of functionality of the nanoparticles is
imperative from application point of view. Investigation of
emission from Tb
3+ from the internalized LaF3:Tb
3+(5%)
nanoparticles-loaded PSS/PAH capsules by HeLa cell was
needed, to assess the optical properties of the nanoparticles post
uptake process and while inside the cell. HeLa cells were imaged
by CLSM post uptake of LaF3:Tb
3+(5%) nanoparticles-loaded
PSS/RITC-PAH capsules and the characteristic green emission
from Tb
3+ was observed (Figure 9) confirming the presence of
Tb
3+ doped nanoparticles in a functional state inside the cell. The
green emission (from Tb
3+) localized with the red emission from
RITC-PAH of the polymer wall of the capsules thus confirming
the presence of nanoparticles inside the capsules in which they
were loaded.
In vitro cytotoxicity of LaF3:Tb
3+ (5%), GdF3:Tb
3+ (5%), and Au
nanoparticles-loaded PSS/PAH capsules was studied on HeLa
cells by MTT assay, so as to investigate the effect of internalization
of these nanoparticles-loaded capsules on cell viability. It was
observed that cell proliferation percentages for Au, LaF3:Tb
3+(5%)
and GdF3:Tb
3+(5%) nanoparticles-loaded polymer capsules were
nearly similar to that of non-treated cell control and blank capsules
(Figure 10). It clearly suggests that nanoparticles-loaded polymer
capsules show less/no cytotoxicity on HeLa cells, thus confirming
their biocompatibility.
Thus a generic way of delivering Au nanoparticles and
LaF3:Tb
3+(5%) nanoparticles to HeLa cells was shown via PSS/
PAH capsules and validated by CLSM and flow cytometry. We
note that both the types of nanoparticles have been delivered
intracellularly without the need of any surface modification for
individual nanoparticles. Furthermore, this strategy can be
extended for delivery of other nanoparticles also, as the method
of loading nanoparticles inside the capsules employs a generic
approach. Additionally, the fluorescence emission from Tb
3+ was
observed even after the uptake of Tb
3+ doped nanoparticles-
loaded PSS/PAH capsules by the cell, indicating the presence of
nanoparticles in their functional state inside the cell and showing
their potential as bioimaging agents. Further it was observed that
these nanoparticles-loaded capsules show less or no cytotoxicity
to the cells post uptake (in comparison to blank capsules or
untreated cells), suggesting their in vitro compatibility with
biological systems.
In conclusion, a general and facile delivery approach to deliver
variety of nanoparticles to cells without individual nanoparticles
surface modification has been demonstrated. Loading of different
kinds of nanoparticles (Au, Ag, CdS, LaF3:Tb
3+, GdF3:Tb
3+,
LaVO4:Eu
3+) inside the polymer capsules supports the generality
and versatility of the method. Additionally, different morphology
of gold nanostructures (nanorods, nanoprisms and multifaceted
nanostructures) and co-loading of Au and LaVO4:Eu
3+ nanopar-
ticles further demonstrates the versatility of our approach. Delivery
of LaF3:Tb
3+ and Au nanoparticles to HeLa cells thorough
polymer capsules as a carrier have been shown. This clearly
suggests that this approach can be used as a general method to
deliver a payload of different types of nanoparticle without the
need of individual nanoparticle surface modification. Further-
more, these nanoparticles-loaded polymer capsules show high
biocompatibility and efficient internalization within the cells.
Green fluorescence emission from internalized LaF3:Tb
3+nano-
particle-loaded polymer capsules in HeLa cells demonstrates their
Figure 6. Nanoparticles in different sizes of capsules. TEM image of Au nanoparticles loaded (a) 1 mm sized PSS/PAH capsules and (b) cross-
linked PAH nanocapsules (,400 nm).
doi:10.1371/journal.pone.0036195.g006
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loaded capsules can have potential applications in multimodal
bioimaging and drug delivery.
Materials and Methods
Materials
All the lanthanide salts, poly-(sodium 4-styrene sulfonate) (PSS,
Mw 70 kDa), poly-(allylamine hydrochloride) (PAH, Mw 70 kDa),
Figure 7. Kinetics of uptake of nanoparticles-loaded capsules by HeLa cells. Cell uptake kinetics of nanoparticles-loaded PSS/PAH capsules
by HeLa cells followed by scanning electron microscopy (a–c) and fluorescence microscopy (d–f) as a function of time 2 h (a and d), 5 h (b and e) and
8 h (c and f). To visualize the uptake by fluorescence microscopy, LaF3:Tb
3+(5%) nanoparticles were loaded in RITC-labeled PSS/PAH capsules (red
emission) and actin cytoskeleton of cells was stained with FITC-Phalloidin (green). In SEM micrographs, nanoparticles-loaded capsules are indicated
by white arrows.
doi:10.1371/journal.pone.0036195.g007
Figure 8. Uptake of nanoparticles-loaded PSS/PAH capsules by HeLa cells. (a) Confocal laser scanning microscopy (CLSM) image of HeLa
cells after uptake of LaF3:Tb
3+(5%) nanoparticles-loaded PSS/PAH capsule. Inset shows high magnification image of a HeLa cell, which has internalized
Au nanoparticles-loaded capsule. Actin cytoskeleton of cells was stained with FITC-Phalloidin (green). The outer PAH layer of the capsules is labeled
with RITC (red) and (b) efficiency of uptake of Au nanoparticles-loaded PSS/PAH capsules and blank PSS/PAH capsules by HeLa cells as investigated
by flow cytometry. Efficiency of uptake is represented by percentage positive cells i.e. cells associated (both internalized and bound) with capsules.
doi:10.1371/journal.pone.0036195.g008
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EDTA, dulbecco’s modified eagle’s medium (DMEM), penicillin-
streptomycin antibiotic, (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT), and gelatin (from cold water
fish skin) were purchased from Sigma Aldrich and used without
further purification. Sodium borohydride and dimethyl sulph-
oxide were obtained from Merck’s chemicals, India. Fetal bovine
serum and chloroauric acid were bought from Hyclone (UT,
USA) and LOBA Chemie, India respectively. Hydrofluoric acid,
CTAB and cadmium nitrate were obtained from S.D. fine chem.
Ltd. Silver nitrate, sodium sulfide, sodium chloride, liquor
ammonia, triethylamine, and methanol were purchased from
Fisher Scientific. 3-aminopropyltriethoxysilane (APTES) and tri
sodium citrate dihydrate was obtained from Spectrochem Pvt.
Ltd and RFCL Ltd. respectively. Citric acid and sodium fluoride
were purchased from Qualigens. Mesoporous silica particles
(5 mm) were purchased from Tessek (Czech Republic). 1 mm
sized silica particles were purchased from microparticles GmbH
(Berlin, Germany). APTES modified mesoporous silica particles
were prepared as described elsewhere [35]. FITC-PAH (Fluo-
rescein isothiocyanate-PAH) and RITC-PAH (Rhodamine B
isothiocyanate-PAH) was obtained by labeling PAH with FITC
and RITC respectively [36]. HeLa cells were purchased from
National Centre for Cell Science Pune, India which is a national
repository of cell lines in India.[/LOOSER]
Preparation of PSS/PAH Capsules
PSS/PAH capsules were prepared as described in detail
elsewhere [37]. Briefly, APTES-modified mesoporous silica
(10 mg, 5 mm in size) were incubated with PSS and PAH
(1 mg/ml of 0.5 M NaCl) solutions alternatively for 15 min to
build-up the layers followed by washing thrice with water.
Typically, five bilayers were developed and the silica core was
removed by treating with 1 ml of 5 M HF for 2 minutes to obtain
the PSS/PAH capsules (Caution: HF is very toxic, so should be handled
with all safety precautions). The capsules were isolated via centrifu-
gation/redispersion cycles (in water). Synthesis of 1 mm sized PSS/
PAH capsules were done in a similar by templating 1 mm sized
silica particles.
Synthesis of Cross-linked PAH Nanocapsules
For synthesis of cross-linked PAH nanocapsules, SC/MS (solid
core mesoporous shell) silica template particles were synthesized as
reported [38]. PAH nanocapsules were prepared as described by
Wang et al [39]. In brief, the SC/MS template silica particles were
taken and polymer was infiltrated in the mesoporous shell by
incubating the template particles with PAH solution (5 mg/ml in
0.2 M NaCl; pH 8.5) for overnight with gentle mixing. Post
infiltration, the unbound polymer was washed off thrice in water
by centrifugation. The polymer was then cross-linked by in-
cubating the polymer-infiltrated particles with glutaraldehyde for
Figure 9. CLSM images showing the characteristic emission of Tb
3+ from the HeLa cell internalized LaF3:Tb
3+(5%) nanoparticles-
loaded PSS/RITC-PAH capsule. (a) Composite image of bright field and fluorescent signals arising from LaF3:Tb
3+(5%) nanoparticles (green
emission from Tb
3+) and RITC-PAH (red); and (b) composite image of fluorescent signals arising from LaF3:Tb
3+(5%) nanoparticles (characteristic green
emission from Tb
3+) and RITC-PAH (red) showing internalized LaF3:Tb
3+(5%) nanoparticles-loaded capsules.
doi:10.1371/journal.pone.0036195.g009
Figure 10. In vitro biocompatibility of nanoparticles-loaded
PSS/PAH capsules. MTT assay results of HeLa cells, blank PSS/PAH
capsules, GdF3:Tb
3+(5%), LaF3:Tb
3+(5%), and Au nanoparticles-loaded
PSS/PAH capsules on incubation with HeLa cells.
doi:10.1371/journal.pone.0036195.g010
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template was etched out by incubating them with 2 M HF: 8 M
NH4F (pH 5) to get PAH capsules (Caution: HF is very toxic, so should
be handled with all safety precautions).
Synthesis of Nanoparticles-loaded Polymer Capsules and
Bare Nanoparticles
The PSS/PAH capsules were mixed with stock solution A for
15 min, followed by the incubation with the stock solution B
(15 min). Stock solution C was added to the above and the mixture
was kept under shaking for 1 h at ambient temperature. Excess
nanoparticles formed outside the capsules were removed out by
repeated centrifugation and washing steps with water. This
procedure was followed to prepare Au, Ag, CdS, LaF3:Tb
3+,
GdF3:Tb
3+, and LaVO4:Eu
3+ nanoparticles-loaded PSS/PAH
capsules by taking the respective stock solution (Table S1). Blank
nanoparticles were synthesized by using the above procedure
without templating the capsules. Similar steps were followed to
synthesize gold nanoparticles in 1 mm sized PSS/PAH capsules
and cross-linked PAH nanocapsules.
Synthesis of PSS/PAH Capsules-loaded with Gold
Nanorods, Gold Nanoprisms and Multifaceted Gold
Nanostructures
Gold nanostructures of various shapes were formed inside PSS/
PAH capsules by following the seed mediated approach as
described by Murphy et al., with modifications in seed and ligand
concentrations [32,40]. First seed was synthesized inside PSS/
PAH capsules by dispersing the capsules in 1 ml of aqueous
solution containing 0.25 mM tri sodium citrate and 0.25 mM
chloroauric acid, followed by gentle mixing for 15 minutes. Freshly
prepared ice cold 0.1 (M) sodium borohydride was added to the
capsule solution drop wise while stirring and was left undisturbed
for 2 hrs so as to form gold seeds inside capsules. Then, 900 mlo f
supernatant was removed by centrifuging at 5000 rpm for 4 min
and the remaining solution containing Au nanoparticles loaded
capsules was used as stock seed solution.
For synthesis of gold nanorods, these seed loaded PSS/PAH
capsules (100 ml) were added in 40 ml of growth solution
(containing 0.25 mM chloroauric acid, 0.01 (M) cetyltrimethy-
lammonium bromide (CTAB) and 200 ml of 0.1 (M) freshly
prepared ascorbic acid solution). The color of the solution
changed to reddish brown after 5 min and the stirring was
stopped at that point of time. After 20 min, the nanoparticles-
loaded capsules were separated by centrifugation at 5000 rpm for
4 minutes followed by washing with water and redispersed in
water.
For synthesis of gold nanoprisms, similar protocol as above was
employed but the seed concentration was reduced 2.5 times. For
synthesis of multifaceted gold nanostructures, same steps as in the
above protocol were repeated but CTAB concentration used was
0.1(M) instead of 0.01(M).
Co-loading of Au and LaVO4:Eu
3+(5%) Nanoparticles in
PSS/PAH Capsules
LaVO4:Eu
3+(5%) nanoparticles were first synthesized in PSS/
PAH capsules as per the protocol given above. These La-
VO4:Eu
3+(5%) nanoparticles-loaded capsules were then washed
thrice and Au nanoparticles were prepared in them by the same
method as described for loading of gold nanoparticles in PSS/
PAH capsules.
Co-loading of Au Nanoparticles and RITC-labeled Bovine
Serum Albumin (BSA) in PSS/PAH Capsules
First PSS/PAH capsules were loaded with RITC-labeled BSA
(BSA was labeled with RITC as per the same method as used for
RITC-PAH above) as per the following protocol. 10 mg APTS-
MS was incubated with 0.5 ml of RITC-BSA solution (1 mg/ml in
DW) for ,30 h with gentle mixing. The above particles were then
coated with five bilayers of PSS/PAH. The silica core was then
etched by using 5 M HF and the resulting RITC-BSA loaded
capsules were washed five times with distilled water. These RITC-
BSA loaded capsules were then used for loading of gold
nanoparticles by the same method as described for loading of
gold nanoparticles in PSS/PAH capsules.
Cell Uptake Studies
HeLa cells were cultured in DMEM medium containing heat
inactivated FBS (10% v/v) and penicillin/streptomycin (1% v/v),
grown at 37uC in a humidified atmosphere containing 5% CO2.
To investigate the uptake kinetics as a function of incubation
time of nanoparticles-loaded capsules, HeLa cells were treated
with LaF3:Tb
3+ nanoparticles-loaded PSS/PAH capsules for
different durations (2 h, 5 h, and 8 h; treatment ratio was 50
capsules (nanoparticles-loaded) per seeded cell; capsules were
labeled with RITC-PAH). After the respective treatment, media
was discarded and cells were washed thrice with PBS buffer
(pH 7.4) to remove loosely bound capsules to the cells. Post
washing, these cells were trypsinized by using 0.25% Trypsin-
EDTA to further remove any capsules which have not yet
internalized. The cells were then seeded on cover slips and left for
few hours. After the cells adhered, they were fixed (and stained
with FITC-Phalloidin) and imaged by fluorescence microscopy
and scanning electron microscopy.
To determine cellular uptake of the nanoparticles-loaded
capsules, HeLa cells (10
5) were seeded on glass cover slip
(13 mm, 0.2% gelatin coated) for 20 hours. The cells were then
treated with LaF3:Tb
3+ and Au nanoparticles-loaded PSS/PAH
capsules (capsules were labeled with RITC-PAH, treatment ratio
was 50 capsules (nanoparticles-loaded) per seeded cell) for 16 h.
Further, the cells were washed; actin cytoskeleton of the cells was
stained with FITC-Phalloidin (green) and imaged by confocal laser
scanning microscopy.
Flow Cytometry Studies
HeLa cells (10
5 cells per well) were grown as described above
and the cells were incubated with blank PSS/PAH capsules and
Au nanoparticles-loaded PSS/PAH capsules for 26 h (treatment
ratio was kept same for both blank capsules and nanoparticles-
loaded capsules i.e. 100 capsules per seeded cell). After the
incubation the cells were washed with PBS buffer (pH 7.4) and
trypsinized by using 0.25% Trypsin-EDTA. The cells were then
resuspended in complete media and analyzed by flow cytometry.
The experiments were done in triplicate.
MTT Assay
In vitro cytotoxicity studies of blank PSS/PAH capsules,
GdF3:Tb
3+(5%), LaF3:Tb
3+(5%), and Au nanoparticles-loaded
PSS/PAH capsules with HeLa cells were investigated by MTT
assay [41]. 10
5 cells per well were seeded in a 24 well plate. The
cells were grown for 18 h, followed by changing it with media
containing respective capsules (100 capsules (nanoparticles-loaded)
per seeded cell) and blank capsules (100 capsules per seeded cell).
In the control wells (i.e. only cells), media was added without
capsules. The cells were incubated with the capsules for ,22 h in
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media. 500 mL of basal media having MTT (0.5 mg/ml MTT)
was added to the wells and allowed to incubate for 4 h. Further,
media containing MTT was removed from the wells and 1 ml of
dimethyl sulphoxide (DMSO) was added into each well. The blue
color solution from the wells was transformed into a cuvette and
absorbance at 570 nm was measured. All the assays were done in
triplicate.
Characterization
UV-Vis spectra were recorded from UV-1800 Shimadzu UV
spectrometer. The photoluminescence spectra and decay curves
were recorded using Edinburgh instruments FLSP 920 fluores-
cence system. Emission and lifetime analyses of nanoparticles-
loaded polymer capsules were done by exciting the samples with
an Nd:YAG laser, attached with an optical parametric oscillator
(OPO) with an optical range from 210–2400 nm. 450 W steady
state Xe lamp was used to record the photoluminescence spectra
of bare nanoparticles. The detector used was a red-sensitive Peltier
element cooled Hamamatsu R928-P PMT. All the TEM images
were obtained from FEI Technai G
2 U-Twin (200 KeV) in-
strument. The size and surface morphology of nanoparticles-
loaded capsules and blank capsules were characterized by
Scanning Electron Microscope (SUPRA 40 VP Gemini, Zeiss,
Germany). The Confocal laser scanning microscopy images of
cells were obtained from Leica PCS SP5 confocal microscope (40x,
oil objective). Flow cytometry measurements were done by using
Partec CyFlowH space cell scanner. Number of blank PSS/PAH
capsules and PSS/PAH capsules (loaded with nanoparticles) were
quantified by flow cytometry.
Supporting Information
Figure S1 UV-Vis absorption spectra of Au and Ag bare
nanoparticles.
(TIF)
Figure S2 Lifetime of lanthanide-doped nanoparticles-
loaded polymer capsules. Decay curve of a) La-
VO4:Eu
3+(5%), b) LaF3:Tb
3+(5%), and c) GdF3:Tb
3+(5%) nano-
particles-loaded PSS/PAH capsule. The emission was monitored
at 541 nm for Tb
3+ doped sample and 612 nm for Eu
3+ doped
sample.
(TIF)
Figure S3 Photoluminescence emission spectrum of
blank PSS/PAH capsules. Blank PSS/PAH capsules were
subjected to photoluminescence spectroscopy so as to investigate
the background emission contribution from the blank capsules.
(TIF)
Figure S4 Photoluminescence emission spectra of bare
nanoparticles. Photoluminescence emission spectra of
LaF3:Tb
3+(5%), GdF3:Tb
3+(5%), and LaVO4:Eu
3+(5%) bare
nanoparticles. The emission bands (green and red curve,
Figure 1c) around 544, 584 and 619 nm are assigned to
5D4 to
7F5,
7F4, and
7F3 transitions, respectively of Tb
3+ ions. The
emission bands (black curve) around 591 nm (
5D0 to
7F1), 615 nm
(
5D0 to
7F2), and 696 nm (
5D0 to
7F4) are assigned to Eu
3+ ions.
(TIF)
Figure S5 UV-Vis absorption spectra of 5 mm PSS/PAH
capsules loaded with (a) gold nanorods and (b) multi-
faceted gold nanoparticles.
(TIF)
Figure S6 Co-loading of drug and nanoparticles within
PSS/PAH capsules. Fluorescence microscopy image of PSS/
PAH capsules (,5 mm) co-loaded with RITC-labeled BSA and Au
nanoparticles.
(TIF)
Figure S7 Validation of internalization of nanoparti-
cles-loaded capsules by HeLa cells. Confocal laser scanning
microscopy sections (XY) of HeLa cells after uptake of LaF3:Tb
3+
nanoparticles-loaded PSS/PAH capsules at different Z positions;
(a) basal, (b) inside and (c) apical of the cell, and (d) XY,YZ and
XZ section of the cell. Scale bar is 20 mm.
(TIF)
Figure S8 2D plots of the events recorded with FACS for
uptake studies. (a) HeLa cells, (b) HeLa cells after incubation
with blank PSS/PAH (FITC-PAH) capsules, and (c) HeLa cells
after incubation with Au nanoparticles-loaded PSS/PAH capsules
(FITC-PAH).
(TIF)
Table S1 Stock solutions for preparing the nanoparti-
cles-loaded polymer capsules.
(DOC)
Table S2 Lifetime of lanthanide-doped nanoparticles-
loaded polymer capsules. Average lifetime of Tb
3+ or Eu
3+
ions for different types of nanoparticles inside PSS/PAH capsules.
(DOC)
Scheme S1 Schematic representation for the synthesis
of nanomaterials-loaded PEM capsules. Nanoparticles
were synthesized inside the microvolume of capsules by incubating
the capsules with nanoparticles precursors and citrate as ligand.
(Inset is digital photograph of A) Au, B) Ag, C) LaVO4:Eu
3+(5%),
D) LaF3:Tb
3+(5%), E) CdS, and F) GdF3:Tb
3+(5%) nanoparticles-
loaded PSS/PAH capsules and G) blank PSS/PAH capsules
dispersed in PBS buffer (pH,7.2)).
(TIF)
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